Skip to main content
Clinical Trials/IRCT201212034333N2
IRCT201212034333N2
Completed
未知

Comparison of clinical results of two pharmaceutical products of Riboflavin in corneal collagen Cross-Linking for keratoconus

oor Eye Hospital0 sites60 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Keratoconus.
Sponsor
oor Eye Hospital
Enrollment
60
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
oor Eye Hospital

Eligibility Criteria

Inclusion Criteria

  • The inclusion criterion is the clinical diagnosis of progressive keratoconus with paraclinical confirmation. The criteria of progressive keratoconus is an increase of at least 1D in maximum keratometry, astigmatism, or manifest refraction, or loss of 2 best corrected visual acuity (BCVA) lines or more in the past 12 months. Patients aged 15\-35 years old with keratometry less than 55D and a central corneal thickness less than 400 µ will be selected for the study. Patients with other ocular diseases or a history of ocular surgery will be excluded from the study. Participants discontinue the use of the hard and soft contact lens 3 weeks and 3 days prior to the surgery, respectively.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials